Sunnylife Global, Inc. in Joint Venture With Kang He Biotechnological Group of Taiwan to Develop and Finance China's Healthcare System and Assisted Living Care Center


LOS ANGELES, June 27, 2007 (PRIME NEWSWIRE) -- Sunnylife Global, Inc. (Pink Sheets:SNYL) announced today that on April 28, 2007, it signed a joint venture agreement in Beijing, China with Kang He Biotechnological Group of Taiwan to assist Sunnylife in the development and financing of its World Friendship Hospitals in China and the "Garden of the Silver" assisted living care project in Boatou, Inner Mongolia.

Announcement of the joint venture was pending receipt by Kang He Biotechnological Group of approvals from the government of China to enter into this joint venture with Sunnylife Global, Inc.

Kang He Biotechnological Group is a company that focuses on the research and development of biological healthcare products and management of hospitals. For more than five years, Kang He has been successful in working with China's healthcare industry and serving as a platform for legalizing Taiwan doctors to practice in China.

The joint venture company will participate in the finance and management of the World Friendship Hospitals, as well as in the supervision of the Sunnylife Global, Inc. corporate office in the U.S. As such, the joint venture is expected to expedite Sunnylife's project development and add substantially to its growth potential.

About Sunnylife Global

Sunnylife Global, Inc. has developed a Health Management System (HMS) in conjunction with the Chinese Government Authorities that will result in delivering superior quality health care management to its members. The Company is in multiple joint venture agreements with the World Friendship Hospital Group to renovate and revitalize China's older hospital facilities in order to meet the current International standard. Sunnylife has developed the HMS to meet that standard and is planning to launch in the very near future. In addition, the Company has patented natural, environmentally safe and economically affordable products which it plans to introduce to Chinese consumers through seven different joint venture licensees in China. Sunnylife represents an organization staffed with professional experts in product research, quality acceptance testing, and market development for service to China and the global markets. For more information, please visit www.sunnylifeglobal.com.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. All forward-looking statements attributable to the Company, or persons acting for the Company, are expressly qualified in their entirety by these cautionary statements.



            

Contact Data